Do You Still Get Hungry on Mounjaro?

Mounjaro works as a dual GIP and GLP-1 receptor agonist, activating two gut-hormone pathways involved in appetite regulation and gastric emptying — the only licensed UK weight-loss medicine to do this.
Hunger reduction tends to deepen with each dose increase; the starter dose of 2.5mg is primarily a tolerability step, so appetite changes at that stage are often modest.
Some people find hunger returns in the days just before their next weekly injection, this is normal and worth discussing with your prescriber if it's persistent.
What you eat alongside treatment matters: protein, fibre and staying hydrated all support the appetite-blunting effect and help protect muscle during weight loss.

Most people taking Mounjaro do still feel some hunger, especially in the first few weeks — but it changes in character. Rather than the urgent, hard-to-ignore drive to eat that many describe before treatment, hunger on tirzepatide tends to become quieter and easier to manage. That shift doesn't happen overnight, and it doesn't feel identical for everyone. Mounjaro is a prescription-only medicine; a clinician assesses whether it's right for you before any treatment begins.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How hunger changes across the weeks of Mounjaro treatment, and what to do when it doesn't

Step 1: The first pen, hunger may not disappear straight away

Starting at 2.5mg, Mounjaro's job is to let your body adjust. The dose at this stage is designed to minimise nausea and other gastrointestinal symptoms rather than to produce full appetite suppression. So if you're on your first pen and still reaching for snacks between meals, that's expected, not a sign the medicine isn't working.

Tirzepatide slows how quickly the stomach empties, which physically prolongs the sensation of fullness after eating. It also acts on GIP and GLP-1 receptors in the brain's appetite centres. But those effects build. Most people notice a meaningful shift in hunger signals somewhere between weeks two and eight, often more pronounced after the first or second dose increase. Being hungry on day one of Mounjaro is genuinely common and doesn't predict how treatment will feel at 5mg or beyond.

The NHS tirzepatide information page describes the appetite mechanism clearly if you want the clinical detail alongside what's written here.

Step 2: Dose increases, when appetite suppression typically sharpens

Each four-weekly step up (2.5mg → 5mg → 7.5mg and so on, titrated by your prescriber) tends to bring a more noticeable reduction in hunger. Many people describe reaching a dose where the urge to eat between meals becomes genuinely quiet for the first time, not absent, but background noise rather than a persistent demand.

There is, however, a pattern worth knowing about: the "end-of-week" window. Because Mounjaro is injected once a week, drug levels in the body peak in the days after the injection and gradually taper. Some people notice hunger creeping back on day six or seven. This is not unusual. If it feels significant, it's worth raising with your prescriber at your next review rather than assuming the medicine has stopped working.

How you eat also plays a role. Protein-rich meals tend to work with Mounjaro's gastric-emptying effect rather than against it, helping meals feel satisfying for longer. Our guide to eating well on Mounjaro covers the practical side in detail, and if you're unsure whether certain foods are comfortable on treatment, the page on spicy food and Mounjaro is a good example of the kind of specific questions our prescribers field regularly.

Step 3: When hunger persists, and why that's worth telling your prescriber

Persistent hunger partway through treatment can mean several things. Your dose may not yet be at the level that achieves appetite suppression for you personally, people respond at different points on the titration schedule. Alternatively, sleep quality, stress levels and hydration all influence hunger hormones in ways that interact with treatment. A very low-calorie diet can sometimes backfire, triggering compensatory hunger signals that partly work against tirzepatide's effects.

There's no embarrassment in finding hunger harder to manage than you expected. The question our prescribers hear regularly is whether something should be adjusted, the titration pace, eating patterns, or both. If you're still feeling hungry well into treatment, that conversation is exactly what clinical aftercare is for. You can read about what to do when you're still hungry on Mounjaro and why some people feel hunger persisting even after several dose increases.

If hunger is accompanied by other symptoms (nausea, indigestion, or stomach pain that won't settle) it's worth checking the common questions section or contacting your prescriber promptly. Severe, persistent stomach pain that radiates to the back requires urgent medical attention. The MHRA's Drug Safety Update communications include specific guidance on GLP-1 medicines and pancreatitis for anyone who wants the regulatory detail.

Practical habits that support appetite control on Mounjaro

Tirzepatide does a great deal of the work, but a few consistent habits make a real difference to how well the appetite-blunting effect holds across the week. Protein at every meal is the most consistently useful one: it takes longer to digest, pairs well with slowed gastric emptying, and helps protect lean muscle during weight loss. Aim to build meals around it rather than adding a token amount.

Staying hydrated matters more than it sounds. Thirst and hunger share enough neurological overlap that mild dehydration can register as an urge to eat. A glass of water before a meal is a small habit with a disproportionate effect for many people on treatment.

One practical note on timing: if your injection day falls on a Friday and you're away for a long weekend, or if it coincides with the kind of disrupted eating that comes around payday, a bank holiday or a holiday abroad, a brief disruption to your usual pattern can make end-of-week hunger feel more pronounced. Keeping to your usual meal structure as closely as possible helps. Our weight-loss treatment overview covers what a good lifestyle foundation alongside treatment looks like.

If you're thinking about starting treatment and want to understand the full picture (including how prescribing works and what clinical review involves) a free consultation with our prescribers is the place to begin.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions